Citius Pharmaceuticals's total assets for Q2 2025 were $121.48M, an increase of 0.64% from the previous quarter. CTXR total liabilities were $57.91M for the fiscal quarter, a 11.82% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.